Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

20092,431 citationsJournal Article

Authors

Bevacizumab, alone or in combination with irinotecan, was well tolerated and active in recurrent glioblastoma.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 27, Issue 28, pp. 4733-4740

Field-Weighted Citation Impact: 86.16